logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuji Uehara

National Cancer Center Hospital
H指数:7
被引数:162

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes and genomic features of uncommon EGFR exon 19 deletion subtypes in osimertinib-treated non-small cell lung cancer

奥希替尼治疗非小细胞肺癌中少见EGFR外显子19缺失亚型的临床结局与基因组特征

Lung Cancer
IF4.4
2026-08-310
PRE
Hiroto Hatano; Tatsuya Yoshida; Ryoko Inaba Higashiyama; Masayuki Shirasawa; Yoshiro Nakahara; Katsuhiko Naoki; Hiroshi Nokihara; Kentaro Gosho; Yuji Uehara; Yukio Hosomi; Ayu Kiritani; Hiroshi Wakui; Yuki Shinno; Yusuke Okuma; Hidehito Horinouchi; Noboru Yamamoto; Yasushi Goto
Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model from the Japan Lung Cancer Society Integrated Phase II–III Database

基于日本肺癌协会整合的II–III期数据库，利用基线临床因素预测局部晚期非小细胞肺癌的放射性食管炎

Clinical Lung Cancer
IF3.3
2026-04-240
PRE
Yuji Uehara; Kageaki Watanabe; Jun Tamura; Yuichi Ozawa; Makiko Yomota; Keigo Kishino; Takayuki Kobayashi; Kentaro Taguchi; Keiko Nemoto Murofushi; Satoshi Oizumi; Katsuyuki Hotta; Tsuneo Shimokawa; Seiji Niho; Shunichi Sugawara; Isamu Okamoto; Koji Yamamoto; Nobuyuki Yamamoto; Yukio Hosomi
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC – A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)

亚洲胸腺肿瘤研究组（ATORG）关于早期非小细胞肺癌（NSCLC）中循环肿瘤DNA（ctDNA）微小残留病灶（MRD）检测的共识声明——一项Delphi研究

Journal of Thoracic Oncology
IF20.8
2026-03-260
OAAI
Aaron C. Tan; Bin-Chi Liao; Molly Li; David Lee; Yuji Uehara; Lucksamon Thamlikitkul; Jia-Tao Zhang; Meimei Zheng; Chee Khoon Lee; Nick Pavlakis; Thomas John; Ross A. Soo; Anders Skanderup; Pei Jye Voon; Beung-Chul Ahn; Sehhoon Park; Hidetoshi Hayashi; Yasushi Goto; Hidehito Horinouchi; Yasushi Yatabe
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

EGFR酪氨酸激酶抑制剂在携带EGFR外显子19插入突变的非小细胞肺癌患者中的疗效：基于LC-SCRUM-Asia（多机构基因组筛查登记）的临床-基因组学及体外研究分析

LUNG CANCER
IF4.4
2025-04-010
OAAI
Uehara, Yuji; Izumi, Hiroki; Kobayashi, Ikei S.; Matsumoto, Shingo; Hosomi, Yukio; Okuno, Takae; Sugisaka, Jun; Takase, Naoto; Taima, Kageaki; Sasaki, Shinichi; Teranishi, Shuhei; Miyamoto, Shingo; Mori, Masahide; Nakashima, Chiho; Asano, Shuichi; Oi, Hajime; Sakai, Tetsuya; Shibata, Yuji; Udagawa, Hibiki; Sugiyama, Eri; Nosaki, Kaname; Umemura, Shigeki; Zenke, Yoshitaka; Yoh, Kiyotaka; Ikeda, Sadakatsu; Costa, Daniel B.; Kobayashi, Susumu; Goto, Koichi
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma

肿瘤相关成纤维细胞中实性占优势的组织学和podotlanin的高表达可预测EGFR突变的肺腺癌对奥希替尼的原发性耐药

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-03-011
OA
Uehara, Yuji; Izumi, Hiroki; Taki, Tetsuro; Sakai, Tetsuya; Udagawa, Hibiki; Sugiyama, Eri; Umemura, Shigeki; Zenke, Yoshitaka; Matsumoto, Shingo; Yoh, Kiyotaka; Kubota, Shoko; Aokage, Keiju; Sakamoto, Naoya; Sakashita, Shingo; Kojima, Motohiro; Nagamine, Michiko; Hosomi, Yukio; Tsuboi, Masahiro; Goto, Koichi; Ishii, Genichiro

研究方向

暂未获取到该数据
Y
Yukio Hosomi
H 指数:34论文数:388被引数:9,225
K
Kageaki Watanabe
H 指数:13论文数:95被引数:605
T
Taiki Hakozaki
H 指数:17论文数:127被引数:1,171
M
Makiko Yomota
H 指数:14论文数:77被引数:585
R
Razelle Kurzrock
H 指数:144论文数:2,328被引数:8.7万
J
Jason K. Sicklick
H 指数:52论文数:361被引数:1.1万
T
Takayuki Kobayashi
H 指数:48论文数:846被引数:9,350
H
Hiroto Hatano
H 指数:2论文数:19被引数:8
S
Shumei Kato
H 指数:47论文数:427被引数:1.1万
D
Daisuke Nishizaki
H 指数:14论文数:85被引数:558